Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Primary pain is in the lower back region bound between the lowest rib and the crease of the buttocks~* Low back pain is of musculoskeletal origin wherein the etiology is lumbar sprain or strain~* Diagnosis is based on positive supportive patient history, physical examination, medication use history and review of relevant records and diagnostic tests~* Low back pain is episodic chronic, defined as pain having occurred on at least 15 days of each of the preceding 3 months, with each individual episode having lasted at least 24 hours followed by a subsequent period of at least 24 hours without pain~* Self-reported Degree of Pain rating on the 0-100 Visual Analog Scale (VAS) scale of 40 or greater~* Subject is willing and able to refrain from consuming any over-the-counter or prescription medications, including herbal supplements for the relief of pain or inflammation, including muscle relaxants throughout study participation, except for the study pain relief medication~* Subject is willing and able to refrain from non-study procedure therapies for low back pain throughout study participation~* Primary language is English~Exclusion Criteria:~* Low back pain is undiagnosed, or has been diagnosed as in whole or in part due to mechanical, inflammatory: neoplastic, metabolic or psychosomatic origins~* Non-organic pain, defined as positive findings for 3 or more of the 5 signs in the 'Waddell's Signs of Inorganic Behavior' list~* Known herniated disc injury~* Known osteoporosis with compression fractures~* Osteoporosis defined as a Total SCORE on the Simple Calculated Osteoporosis Risk Estimation (SCORE) screening questionnaire of \> 6, and a Dual-Energy X-ray Absorptiometry (DEXA) T-score ≤ -2.5~* Congenital deformity of the spine~* Current, active chronic pain disease~* Cancer or treatment for cancer in the past 6 months, including spinal cord tumors~* Use of the analgesics paracetamol, compound analgesics or topical analgesics within 7 days prior to treatment~* Use of the muscle relaxants cyclobenzaprine (Lexeril, Fexmid), diazepam (Valium) or meprobamate (Miltown®, Equinil®, Equagesic®, Meprospan®) within 30 days prior to treatment~* Use of the muscle relaxants Carisoprodol (Soma®, Sodol®, Soprodol®, Soridol®) or Metaxalone (Skelaxin, Robaxin) within 7 days prior to treatment~* Use of the antidepressants duloxetine (Cymbalta®, Effexor), amitriptyline, imipramine (Tofranil), clomipramine (Anafranil), nortriptyline (Pamelor), desipramine (Norpramin) or selective serotonin reuptake inhibitors (SSRIs) e.g. Paxil, paroxetine, fluoxetine (Prozac) initiated within 30 days prior to treatment~* Consumption of systemic corticosteroid therapy or narcotics within 30 days prior to treatment~* Local or epidural injection of corticosteroids in the back within 3 months prior to treatment~* Botulinum toxin (Botox®) injection for chronic low back pain within 4 months prior to treatment~* Active infection, wound or other external trauma to the treatment areas~* Prior surgery to the back or spine~* Medical, physical or other contraindications for, or sensitivity to, light therapy~* Pregnant, breast feeding, or planning pregnancy prior to study end~* Serious known mental health illness such as dementia or schizophrenia; psychiatric hospitalization in past two years~* Mental illness/incompetence defined according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) definition and criteria~* Current and/or prior history of alcohol and/or other substance abuse, defined according to the DSM-V definition and criteria~* Developmental disability or cognitive impairment that may compromise study participation~* Involvement in litigation or receiving disability benefits related to the study parameters~* Participation in a clinical study or other type of research in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Erchonia FX-635 (Type: ACTIVE_COMPARATOR): The Erchonia FX-635 is made up of 3 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices with flexible arms positioned equidistant from each other.
- Placebo Laser (Type: PLACEBO_COMPARATOR): The Placebo Laser has the same appearance as the Erchonia FX-635 but does not emit any therapeutic light.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete